Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q2 EPS by 44c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $87.25 -2.23%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of $0.41, $0.44 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $151.81 million versus the consensus estimate of $112.72 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
- Hyperion DeFi (HYPD) Tops Q2 EPS by 57c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
